─Scientific Misconduct. DocuSign Envelope ID: EF8E297B-24F7-43A7-9300-33B5DAA4095F
─Scientific Misconduct. The Vendor shall set out a procedure for the inquiry, investigation, appeal, and disposition of complaints alleging misconduct in activities involving any and all research projects funded, in whole or in part, with federal funds included in this Contract, and as authorized under the Public Health Services research grants. Such policies and procedures shall be in accordance with the provisions of 42 CFR 50.101 to 50.104 and CHFS Policy for Responding to Allegations of Scientific Misconduct as amended, and shall be made available, upon request, to the Cabinet for Health and Family Services. The Vendor shall immediately report to CHFS any activity reported to the Vendor under these terms and conditions. Notice shall be sent in writing to the Department. DocuSign Envelope ID: EF8E297B-24F7-43A7-9300-33B5DAA4095F
─Scientific Misconduct. 33.3.1 Prohibit intimidation or coercion of scientists to alter scientific data, findings, or professional opinions or non-scientific influence of scientific advisory boards. In addition, recipient employees, contractors, and program participants, including scientists, managers, and other leadership, shall not knowingly misrepresent, exaggerate, or downplay areas of scientific uncertainty.
33.3.2 Prohibit retaliation or other punitive actions toward recipient employees who uncover or report allegations of scientific and research misconduct, or who express a differing scientific opinion. Employees who have allegedly engaged in scientific or research misconduct shall be afforded the due process protections provided by law, regulation, and applicable collective bargaining agreements, prior to any action. Recipients shall ensure that all employees and contractors of the recipient shall be familiar with these protections and avoid the appearance of retaliatory actions.
33.3.3 Require all recipient employees, contractors, and program participants to act honestly and refrain from acts of research misconduct, including publication or reporting, as described in EPA’s Policy and Procedures for Addressing Research Misconduct, Section 9.C. Research misconduct does not include honest error or differences of opinion. While EPA retains the ultimate oversight authority for EPA-supported research, grant recipients conducting research bear primary responsibility for prevention and detection of research misconduct and for the inquiry, investigation, and adjudication of research misconduct alleged to have occurred in association with their own institution.
33.3.4 Take the actions required on the part of the recipient described in EPA’s Policy and Procedures for Addressing Research Misconduct, Sections 6 through 9, when research misconduct is suspected or found.
─Scientific Misconduct. The Contractor shall set out a procedure for the inquiry, investigation, appeal, and disposition of complaints alleging misconduct in activities involving any and all research projects funded, in whole or in part, with federal funds included in this Contract, and as authorized under the Public Health Services research grants. Such policies and procedures shall be in accordance with the provisions of 42 CFR Part 50 and 900 KAR 1:080, as amended, and shall be made available, upon request, to CHFS. The Contractor shall immediately report to CHFS any activity reported to the Contractor under these terms and conditions. Notice shall be sent in writing to the Department.
─Scientific Misconduct. The Vendor shall set out a procedure for the inquiry, investigation, appeal, and disposition of complaints alleging misconduct in activities involving any and all research projects funded, in whole or in part, with federal funds included in this Contract, and as authorized under the Public Health Services research grants. Such policies and procedures shall be in accordance with the provisions of 42 CFR 50.101 to 50.104 and 900 KAR 1:080 as amended, and shall be made available, upon request, to the Cabinet for Health and Family Services. The Vendor shall immediately report to CHFS any activity reported to the Vendor under these terms and conditions. Notice shall be sent in writing to the Department.
─Scientific Misconduct. Subcontractor hereby certifies that it has established procedures for dealing with and reporting possible misconduct in science as set forth in 42 CFR Part 50, Subpart A. The term “Scientific Misconduct” means, the fabrication, falsification, plagiarism, or other practices that seriously deviate from those that are commonly accepted within the scientific community for proposing, conducting, or reporting research.
─Scientific Misconduct. The Second Party shall set out a procedure for the inquiry, investigation, appeal, and disposition of complaints alleging misconduct in activities involving any and all research projects funded, in whole or in part, with federal funds included in this Agreement, and as authorized under the Public Health Services research grants. Such policies and procedures shall be in accordance with the provisions of 42 CFR 50.101 to 50.104 and 900 KAR 1:080 as amended, and shall be made available, upon request, to the Cabinet for Health and Family Services. The Second Party shall immediately report to CHFS any activity reported to the Second Party under these terms and conditions. Notice shall be sent in writing to the Cabinet for Health and Family Services, Cabinet for Health and Family Services, Department for Community Based Services, 000 Xxxx Xxxx Xxxxxx, 0X-X, Xxxxxxxxx, XX 00000.
─Scientific Misconduct. CWRU hereby certifies that it has established procedures for dealing with and reporting possible misconduct in science as set forth in 42 CFR Part 50, Subpart A. The term "Scientific Misconduct" means, the fabrication, falsification, plagiarism, or other practices that seriously deviate from those that are commonly accepted within the scientific community for proposing, conducting, or reporting research.
─Scientific Misconduct. The Vendor shall set out a procedure for the inquiry, investigation, appeal, and disposition of complaints alleging misconduct in activities involving any and all research projects funded, in whole or in part, with federal funds included in this Contract, and as authorized under the Public Health Services research grants. Such policies and procedures shall be in accordance with the provisions of 42 CFR 50.101 to 50.104 and CHFS Policy for Responding to Allegations of Scientific Misconduct as amended, and shall be made available, upon request, to the
─Scientific Misconduct. Scientific misconduct, as formulated in the DFG memorandum of good scientific practice, e.g. the production and use of incorrect data, the impairment of others research work, the disregard of third parties intellectual property rights must be avoided in any case (see also recommendations of the DFG). The Xxxx xxx Xxxxxxxxx University of Xxxxxxxxx has appointed two trusted third parties who can be contacted in cases of suspected scientific misconduct. Furthermore, the University’s Commission for Research Assessment and Ethics is entrusted with investigating suspected scientific misconduct. Rules of procedure and deadlines for the investigation of suspected cases have been established in order to define the rights of the involved parties. The type of sanction shall depend on the seriousness of the proven misconduct and includes consequences for the employment relationship, civil law penalties or fines for those responsible. The Xxxx xxx Xxxxxxxxx University Oldenburg has defined the procedures in cases of suspected scientific misconduct in a Code of Procedure (German only), which is to be found in the official notices:
